Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nanoparticles use magnetoelectricity to target and eradicate cancer cells.
Bryant JM, Stimphil E, Andre V, Shotbolt M, Zhang E, Estrella V, Husain K, Weygand J, Marchion D, Lopez AS, Abrahams D, Chen S, Abdel-Mottaleb M, Conlan S, Oraiqat I, Khatri V, Guevara JA, Pilon-Thomas S, Redler G, Latifi K, Raghunand N, Yamoah K, Hoffe S, Costello J, Frakes JM, Liang P, Khizroev S, Gatenby RA, Malafa M. Bryant JM, et al. Among authors: pilon thomas s. bioRxiv [Preprint]. 2024 Oct 15:2024.10.13.618075. doi: 10.1101/2024.10.13.618075. bioRxiv. 2024. PMID: 39464093 Free PMC article. Preprint.
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer.
Smalley TB, Nicolaci A, Tran KC, Lokhandwala J, Obertopp N, Matlack JK, Miner RE 3rd, Teng MN, Pilon-Thomas S, Binning JM. Smalley TB, et al. Among authors: pilon thomas s. bioRxiv [Preprint]. 2024 Oct 17:2024.10.17.618959. doi: 10.1101/2024.10.17.618959. bioRxiv. 2024. PMID: 39464070 Free PMC article. Preprint.
Tumor-infiltrating lymphocytes: A new hope.
Sarnaik AA, Hwu P, Mulé JJ, Pilon-Thomas S. Sarnaik AA, et al. Among authors: pilon thomas s. Cancer Cell. 2024 Aug 12;42(8):1315-1318. doi: 10.1016/j.ccell.2024.06.015. Epub 2024 Jul 18. Cancer Cell. 2024. PMID: 39029463 Review.
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0.
Markowitz J, Shamblott M, Brohl AS, Sarnaik AA, Eroglu Z, Khushalani NI, Dukes CW, Chamizo A, Bastawrous M, Garcia ET, Dehlawi A, Chen PL, De Aquino DB, Sondak VK, Tarhini AA, Kim Y, Lawman P, Pilon-Thomas S. Markowitz J, et al. Among authors: pilon thomas s. Mol Cancer Ther. 2024 Aug 1;23(8):1139-1143. doi: 10.1158/1535-7163.MCT-23-0652. Mol Cancer Ther. 2024. PMID: 38657233 Free PMC article. Clinical Trial.
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products.
Stewart MD, Kalos M, Coutinho V, Better M, Jazayeri J, Yohrling J, Jadlowsky J, Fuchs M, Gidwani S, Goessl C, Hanley PJ, Healy J, Liu W, McKelvey BA, Pearce L, Pilon-Thomas S, Andrews HS, Veldman M, Vong J, Weinbach SP, Allen JD. Stewart MD, et al. Among authors: pilon thomas s. Cytotherapy. 2024 Jul;26(7):778-784. doi: 10.1016/j.jcyt.2024.03.009. Epub 2024 Mar 16. Cytotherapy. 2024. PMID: 38583170 Free article.
L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy.
Jardim-Perassi BV, Irrera P, Oluwatola OE, Abrahams D, Estrella VC, Ordway B, Byrne SR, Ojeda AA, Whelan CJ, Kim J, Beatty MS, Damgaci-Erturk S, Longo DL, Gaspar KJ, Siegers GM, Centeno BA, Lau JYC, Pilon-Thomas SA, Ibrahim-Hashim A, Gillies RJ. Jardim-Perassi BV, et al. Among authors: pilon thomas sa. Biomedicines. 2024 Feb 19;12(2):461. doi: 10.3390/biomedicines12020461. Biomedicines. 2024. PMID: 38398062 Free PMC article.
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients.
Dukes CW, Potez M, Lancet J, Kuter BJ, Whiting J, Mo Q, Leav B, Wang H, Vanas JS, Cubitt CL, Isaacs-Soriano K, Kennedy K, Rathwell J, Diaz Cobo J, O'Nan W, Sirak B, Dong N, Tan E, Hwu P, Giuliano AR, Pilon-Thomas S. Dukes CW, et al. Among authors: pilon thomas s. Vaccines (Basel). 2023 Dec 22;12(1):13. doi: 10.3390/vaccines12010013. Vaccines (Basel). 2023. PMID: 38250826 Free PMC article.
92 results